Physician profile
Mark A Falvo
NPI 1699966242
$5,418.54
in general payments reported to CMS, 2019-2025
22 companies · $224 in 2025
The $224 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $725 · 2020: $405 · 2021: $512 · 2022: $1,082 · 2023: $1,429 · 2024: $1,042 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,694.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $805.85 | 2019-2022 | |
| Medtronic, INC. | $756.06 | 2022-2024 | Progrip, Sonicision, Signia |
| Integra Lifesciences Corporation | $626.37 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ethicon US, LLC | $465.99 | 2020-2024 | Vistaseal, Ethicon, Echelon Flex |
| Fujifilm Healthcare Americas Corporation | $371.11 | 2023-2024 | Fujifilm |
| Axonics, INC. | $288.32 | 2020-2024 | Axonics |
| Thd America, INC. | $242.51 | 2021-2023 | |
| Activ Surgical, INC. | $197.45 | 2023 | Activsight |
| Coloplast Corp | $189.75 | 2023-2024 | Sensura Mio |
| Pentax of America, INC. | $189.41 | 2022-2024 | Inspira, Pentax Medical, C2 Cryoballoon Focal Controller |
| Exact Sciences Corporation | $188.00 | 2023-2024 | Cologuard Collection Kit |
| Tela Bio, INC. | $172.94 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Conmed Corporation | $161.13 | 2020-2025 | Airseal |
| Boston Scientific Corporation | $148.78 | 2019-2022 | |
| Innovation Technologies INC | $142.91 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $142.45 | 2019-2022 | |
| Kci USA, INC. | $118.18 | 2022 | |
| Sanara Medtech INC. | $104.89 | 2024 | Celleraterx |
| Merck Sharp & Dohme LLC | $30.48 | 2020-2022 | |
| Hollister Incorporated | $30.03 | 2022 | |
| Abbott Laboratories | $27.99 | 2019-2021 | |
| Covidien LP | $17.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Falvo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.